FOXM1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemFOXM1 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-43769-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Nameforkhead box M1
NCBI Gene AliasesFKHL16, FOXM1A, FOXM1B, FOXM1C, HFH-11, HFH11, HNF-3, INS-1, MPHOSPH2, MPP-2, MPP2, PIG29, TRIDENT

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1American journal of cancer researchJanuary 1, 2022Zhang Z, Liu W, Bao X, Sun T, Wang J, Li M, Liu C.

(3) The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutationsNeuro-oncology advancesJanuary 1, 2020Deng J, Hua L, Han T, Tian M, Wang D, Tang H, Sun S, Chen H, Cheng H, Zhang T, et al.

(4) Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinomaCancer biomarkers : section A of Disease markersJanuary 1, 2020Su WL, Chuang SC, Wang YC, Chen LA, Huang JW, Chang WT, Wang SN, Lee KT, Lin CS, Kuo KK.

(5) Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1Acta biochimica et biophysica SinicaDecember 13, 2019Chen A, Xu C, Luo Y, Liu L, Song K, Deng G, Yang M, Cao J, Yuan L, Li X.

(6) Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cellsOncology reportsAugust 1, 2019Yan D, Yan X, Dai X, Chen L, Sun L, Li T, He F, Lian J, Cai W.

(9) The FoxM1-ABCC4 axis mediates carboplatin resistance in human retinoblastoma Y-79 cellsActa biochimica et biophysica SinicaSeptember 1, 2018Zhu X, Xue L, Yao Y, Wang K, Tan C, Zhuang M, Zhou F, Zhu L.

(11) Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathwayOncotargetMarch 30, 2018Nicolau-Neto P, Da Costa NM, de Souza Santos PT, Gonzaga IM, Ferreira MA, Guaraldi S, Moreira MA, Seuánez HN, Brewer L, Bergmann A, et al.

(13) Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancerFree radical biology & medicineFebruary 1, 2018Ciamporcero E, Daga M, Pizzimenti S, Roetto A, Dianzani C, Compagnone A, Palmieri A, Ullio C, Cangemi L, Pili R, et al.

(15) Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous LeukemiaClinical cancer research : an official journal of the American Association for Cancer ResearchFebruary 1, 2017Jin B, Wang C, Li J, Du X, Ding K, Pan J.

(16) Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancerTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineAugust 1, 2016Li L, Fan B, Zhang LH, Xing XF, Cheng XJ, Wang XH, Guo T, Du H, Wen XZ, Ji JF.

(19) FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progressionInternational journal of clinical and experimental pathologyJanuary 1, 2015Jiang W, Zhou F, Li N, Li Q, Wang L.

FOXM1 shRNA Plasmid (h)